Prospects of Mendelian randomization in hepatology: a comprehensive literature review with practice guidance
Lanlan Chen(Jilin University), Menghan Gao(Jilin University), Guoyue Lv(Jilin University), Qi Rao(Huanggang Central Hospital)
Cited by 9
Related Papers
Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP‐2/‐9
|Fundamental and Clinical Pharmacology|2023|31
Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization
|Frontiers in Pharmacology|2022|13
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
|Oncology Letters|2022|12
The role of natural killer T cells in liver transplantation
|Frontiers in Cell and Developmental Biology|2024|7
Tunable Synthetic Hydrogel Modulates Hepatic Lineage Specification of Human Liver Organoid
|Advanced Functional Materials|2025|4